Acupuncture for Sepsis

Overseen By Jun Mao, MD, MSCE

Age: 18+

Sex: Any

Trial Phase: Phase 2

Sponsor: Memorial Sloan Kettering Cancer Center

Disqualifiers: ICU admission, Implanted device, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Prior Safety Data This treatment has passed at least one previous human trial

Approved in 4 Jurisdictions This treatment is already approved in other countries

Compensation: Varies

Number of Visits: Unknown

Duration: Up to 2 years

78 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if acupuncture can improve outcomes for people with sepsis, a serious infection that spreads throughout the body. Participants will receive either real acupuncture or sham acupuncture, which mimics the real procedure but doesn't target the same body points. The goal is to see if real acupuncture offers any benefits over the sham version. This trial suits individuals who have started a sepsis treatment plan within the last 48 hours. As a Phase 2 trial, the research focuses on measuring the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to important medical advancements.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that acupuncture can be safely used alongside regular treatments for sepsis. Some studies suggest that acupuncture may improve recovery for people with sepsis, making it a useful addition to standard care without causing extra harm.

Previous patient outcomes have demonstrated that acupuncture can help balance the immune system, which is crucial in fighting sepsis. Animal studies also suggest that acupuncture can protect vital organs like the brain, heart, and kidneys from damage caused by sepsis.

Overall, acupuncture is generally well-tolerated in humans and does not have major side effects. This makes it a promising option to explore in clinical trials for sepsis. ^{1 2 3 4 5}

Why do researchers think this study treatment might be promising for sepsis?

Researchers are excited about using acupuncture for sepsis because it offers a unique, drug-free approach that taps into the body's natural healing processes. Unlike standard treatments for sepsis, which often rely on antibiotics and supportive care measures like fluids and oxygen, acupuncture aims to modulate the immune system and reduce inflammation through targeted stimulation of specific points on the body. This ancient practice could potentially provide a complementary therapy that enhances recovery without the side effects associated with pharmaceuticals.

What evidence suggests that acupuncture might be an effective treatment for sepsis?

Research shows that acupuncture, which participants in this trial may receive, might help people with sepsis. Studies have found that adding acupuncture to regular treatment can reduce inflammation in sepsis patients. Reducing inflammation is important because it can lead to better recovery. Animal studies also suggest that acupuncture might protect organs like the brain, heart, and kidneys from sepsis-related damage. These findings offer hope that acupuncture could improve outcomes for those suffering from this serious condition. ^{1 3 5 6 7}

Who Is on the Research Team?

Gary Deng, MD, PhD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Are You a Good Fit for This Trial?

This study is for individuals at high risk of developing sepsis, possibly due to conditions like pre-eclampsia. Participants must meet certain health criteria to join, but specific inclusion and exclusion details are not provided.

Inclusion Criteria

Having MSK sepsis order-set placed within the previous 24 hours

Exclusion Criteria

The patient is on a clinical trial and its Principal Investigator does not give approval to enrollment to this study

Admitted to ICU before being approached for consenting

I cannot give consent for myself and have no one to do it on my behalf.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either real acupuncture or sham acupuncture to assess its impact on sepsis outcomes

Up to 2 years

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Acupuncture
• Sham Acupuncture

Trial Overview The trial is testing whether real acupuncture can improve outcomes in patients at high risk for sepsis compared to sham acupuncture, which mimics the procedure without targeting the same points or using the same needles.

How Is the Trial Designed?

Group I: Acupuncture Experimental Treatment 1 Intervention

Group II: Sham Acupuncture Placebo Group 1 Intervention

Acupuncture is already approved in United States, European Union, China for the following indications:

Approved in United States as Acupuncture for:

• Pain management
• Hot flashes
• Fatigue
• Sleep disturbances
• Anxiety
• Depression
• Neuropathy

Approved in European Union as Acupuncture for:

• Pain management
• Hot flashes
• Fatigue
• Sleep disturbances
• Anxiety
• Depression

Approved in China as Acupuncture for:

• Pain management
• Hot flashes
• Fatigue
• Sleep disturbances
• Anxiety
• Depression
• Neuropathy

Who Is Running the Clinical Trial?

Memorial Sloan Kettering Cancer Center

Lead Sponsor

Trials

1,998

Recruited

602,000+

Published Research Related to This Trial

Acupuncture can lead to adverse events (AEs), including organ or tissue injuries, infections, local reactions, and other complications, with serious AEs being rare but potentially life-threatening, as highlighted by a review of 17 systematic reviews.

The overall methodological quality of the reviews on acupuncture AEs was mediocre, indicating a need for improved research standards and emphasizing the importance of patient safety and acupuncturist training in practice.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Safety of Acupuncture: Overview of Systematic Reviews. Chan, MWC., Wu, XY., Wu, JCY., et al.[2022]

In a study involving 78 acupuncturists and 31,822 consultations, the incidence of adverse events was found to be 684 per 10,000 consultations, indicating that while acupuncture does have risks, they are relatively low when performed by trained professionals.

The most common minor adverse events included bleeding and needling pain, with 70% of symptom aggravations resolving afterward, and only 14 significant adverse events reported, suggesting that acupuncture is generally safe in skilled hands.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Survey of adverse events following acupuncture (SAFA): a prospective study of 32,000 consultations. White, A., Hayhoe, S., Hart, A., et al.[2022]

A review of 23 observational studies on acupuncture-related adverse events revealed that many did not provide sufficient information to determine the cause of complications, highlighting a gap in reporting quality.

The study emphasizes the need for better involvement of acupuncture experts in reporting adverse events to improve the understanding and safety of acupuncture practices, particularly regarding infections.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

The Reporting Quality of Acupuncture-Related Infections in Korean Literature: A Systematic Review of Case Studies. Kim, TH., Kang, JW., Park, WS.[2022]

Acupuncture was found to enhance survival rates and improve neutrophil migration in a rat model of sepsis, suggesting its potential as a treatment for this serious condition.

The study standardized a model using cecal ligation and puncture (CLP) to induce sepsis, allowing for a focused investigation into acupuncture's effects on the infectious process.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Effect of various acupuncture treatment protocols upon sepsis in Wistar rats. Scognamillo-Szabó, MV., Bechara, GH., Ferreira, SH., et al.[2006]

A systematic review of 54 studies suggests that acupuncture at the ST36 point may help reduce organ injuries caused by sepsis, potentially benefiting the heart, lungs, kidneys, liver, gastrointestinal tract, and immune system.

The proposed mechanisms for acupuncture's effects include reducing oxidative stress and inflammation, improving blood flow, and maintaining immune balance, although the overall quality of the studies indicates that more rigorous research is needed to confirm these findings.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Acupuncture at Zusanli (ST36) for Experimental Sepsis: A Systematic Review. Lai, F., Ren, Y., Lai, C., et al.[2022]

In a study of 50 sepsis patients, those receiving electroacupuncture alongside standard treatment showed significant improvements in intestinal permeability and function, as indicated by lower lactulose to mannitol ratios and serum D-lactic acid levels after 3 days.

The combination of electroacupuncture and conventional treatment led to a faster time to target feeding and a higher overall effective rate (80.8% vs. 54.2%) compared to standard treatment alone, suggesting that electroacupuncture may enhance recovery in sepsis patients.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

[Impacts of electroacupuncture on intestinal permeability in sepsis patients]. Wu, JN., Zhu, MF., Lei, S., et al.[2022]

Acupuncture has a relatively low risk of adverse events (AEs), with at least one AE occurring in about 9.31% of patients undergoing treatment, and serious adverse events (SAEs) being very rare at approximately 1.01 per 10,000 patients.

The most common minor AEs are mild reactions such as bleeding or pain at the needle site, which are often considered intended effects of acupuncture, highlighting the need for standardized assessment tools to differentiate between adverse reactions and therapeutic responses.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Acupuncture-related adverse events: systematic review and meta-analyses of prospective clinical studies. Bäumler, P., Zhang, W., Stübinger, T., et al.[2021]

In a study involving 1968 patients across three multicenter randomized controlled trials, only 3.76% experienced adverse events from acupuncture, indicating a low risk associated with this therapy.

The most common adverse events were minor, such as subcutaneous haematoma and needle site pain, and all but one patient recovered within two weeks, suggesting acupuncture is generally safe when performed by skilled practitioners.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Adverse events associated with acupuncture: three multicentre randomized controlled trials of 1968 cases in China. Zhao, L., Zhang, FW., Li, Y., et al.[2021]

Acupuncture significantly improved immune function in sepsis patients, as evidenced by increased levels of T cell subgroups and immunoglobulins after 6 days of treatment, similar to the effects of thymosin alpha1.

Both acupuncture and thymosin alpha1 treatment led to shorter ICU stays, lower hospital readmission rates, and reduced 28-day mortality compared to standard care, indicating their potential as effective adjunct therapies for sepsis.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

[Effect of Acupuncture on Prognosis and Immune Function of Sepsis Patients]. Xiao, QS., Ma, MY., Zhang, XS., et al.[2018]

This systematic review aims to evaluate the efficacy and safety of acupuncture as a complementary therapy for sepsis by analyzing randomized controlled trials (RCTs) from various databases, focusing on outcomes like 28-day mortality and physiological health scores.

The review will also assess inflammatory markers and immune responses, such as TNF-α, IL-6, and T cell counts, to understand the potential mechanisms through which acupuncture may influence sepsis outcomes.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Efficacy and safety of acupuncture as a complementary therapy for sepsis: A protocol of systematic review and meta-analysis. Xian, J., Wang, L., Zhang, C., et al.[2022]

Citations

1. pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov/35579024/

Efficacy and safety of acupuncture as a complementary ... The available evidence showed that combination of acupuncture and routine therapy may have benefit for sepsis compared with use of routine therapy only.

2. sciencedirect.com sciencedirect.com/science/article/pii/S1003525725000947

Acupuncture as an adjunctive therapy for sepsis Multiple clinical studies have demonstrated that acupuncture can lower serum inflammatory factor levels in patients with sepsis, reduce systemic ...

3. journals.lww.com journals.lww.com/md-journal/fulltext/2019/11290/efficacy_and_safety_of_acupuncture_as_a.25.aspx

Efficacy and safety of acupuncture as a complementary... Several studies showed that acupuncture maybe benefit for sepsis. The benefit may be related to the fact that acupuncture can reduce inflammation and regulate ...

4. frontiersin.org frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1003658/full

Traditional Chinese medicine for treatment of sepsis and ... 4 Acupuncture​​ Electroacupuncture treatment was shown to improve sepsis-related damage of brain, heart, kidney, intestines, and other organs in animal models.

5. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC10518388/

Revealing the biological mechanism of acupuncture in ... Acupuncture can not only effectively inhibit excessive inflammatory reactions but also improve the immunosuppressive state of patients with sepsis, thus ...

6. sciencedirect.com sciencedirect.com/science/article/pii/S1566070221000230

Acupuncture modulates immunity in sepsis Acupuncture modulates immunity and improves organ functions in sepsis, emerging as a promising therapy of immunomodulation. •. Acupuncture obtains its ...

7. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC6890293/

Efficacy and safety of acupuncture as a complementary ... Acupuncture may be useful for sepsis. This systematic review aims to assess the efficacy and safety of acupuncture as a complementary therapy for sepsis.